CD8A and infection: We found that Mtb-specific frequencies of effector T cell phenotypes (i.e., both CD4+ and CD8+) in the blood can be targeted to distinguish infection outcomes, with a clear separation between median trajectories of active versus latent TB late during infection progression (~300 days).